IFNG and Sepsis: Recently, studies have shown that recombinant IFNγ can partially restore metabolic function in tolerized monocytes from patients with sepsis.12 This finding highlights the potential of using innate immune “trainers” to mitigate tolerance as a therapeutic approach.